Newmont Enters into Definitive Agreement to Acquire Newcrest

Newmont Enters into Definitive Agreement to Acquire Newcrest

Setting the Standard for Safe, Profitable and Responsible Gold and Copper Production from a World-Class Portfolio of Top-Tier Operations

  • Newmont has agreed to acquire Newcrest by way of an Australian Scheme of Arrangement (“Scheme”), under which Newmont will acquire 100 percent of the issued shares in Newcrest Mining Limited (“Newcrest”)

  • Newcrest shareholders to receive 0.400 Newmont shares (or 0.400 Newmont CDI1) for each Newcrest share and a special dividend of up to $1.10 per share paid by Newcrest, representing a 30.4 percent premium2
  • Further strengthens Newmont’s position as the responsible gold mining leader through the combination of high-quality operations, projects and reserves concentrated in low-risk jurisdictions, including 10 Tier 1 operations that will support decades of safe, profitable and responsible gold and copper production3
  • Complementary businesses create substantial opportunities for optimization; estimated annual pre-tax synergies of $500 million expected to be achieved within first 24 months4
  • Highly accretive for Newmont shareholders upon closing, with opportunity to enhance near-term cash flows, targeting at least $2 billion in the first two years after closing through portfolio optimization5
  • Maintaining Newmont’s balanced capital allocation priorities and industry-leading dividend framework, which has returned over $4.5 billion to shareholders since established in October 2020

  • The Scheme is unanimously recommended by the Board of Directors of Newcrest, subject to no superior proposal emerging for Newcrest and the Independent Expert concluding that the transaction is in the best interests of Newcrest shareholders

  • The Board of Newmont unanimously recommends6 that Newmont stockholders vote in favor of the required Newmont stockholder resolution

  • Transaction is subject to customary conditions, including shareholder approval, with completion expected in the fourth quarter of 2023

  • Newmont will host investor webcast and conference call on May 15, 2023 at 8:00 a.m. Eastern Daylight Time (10:00 p.m. Australian Eastern Standard Time)

DENVER–(BUSINESS WIRE)–
Newmont Corporation (NYSE: NEM, TSX: NGT) today announced that following completion of due diligence it has entered into a binding Scheme Implementation Deed (“SID”) under which Newmont will acquire 100 percent of the issued share capital in Newcrest by way of an Australian court-approved Scheme of Arrangement (the “Scheme” or the “Transaction”).

“The combination of Newmont and Newcrest represents an exceptional value proposition for shareholders and other stakeholders. It creates an industry-leading portfolio with a multi-decade gold and copper production profile in the world’s most favorable mining jurisdictions,” said Tom Palmer, President and CEO of Newmont. “Following a robust due diligence process, we have identified a number of opportunities to unlock substantial value and will apply our experience and expertise to Newcrest’s complementary and exceptional portfolio of long-life, low-cost gold and copper assets. Leveraging our experience from the acquisition of Goldcorp four years ago, we are positioned to deliver an estimated $500 million in annual synergies and an estimated $2 billion in incremental cash flow from portfolio optimization opportunities, both part of our strategy to maximize value for shareholders and other stakeholders.”

Mr. Palmer continued: “This transaction also increases Newmont’s annual copper production – a metal vital for the new energy economy – and adds nearly 50 billion pounds of copper reserves and resources from Newcrest to our robust and balanced portfolio7. We intend to quickly realize these opportunities to create superior value for our shareholders, workforce, host communities and governments.”

Newcrest’s Chairman, Peter Tomsett, added: “This transaction combines two of the world’s leading gold producers, bringing forward significant value to Newcrest shareholders through the recognition of our outstanding growth pipeline. In addition to the ongoing benefits of merging these premier portfolios, the combined group will set a new benchmark in gold production while benefitting from a material and growing exposure to copper and a market leading position in safety and sustainability. The Newcrest Board is unanimously recommending the proposal. We are very proud of the entire Newcrest team for building a world class metals business, which will form a key part of the combined group. We believe our shareholders and other stakeholders can look forward to an exciting and prosperous future.”

TRANSACTION RATIONALE

The New Sustainability Standard

For the last eight years, Newmont has been recognized as the top gold miner in the Dow Jones Sustainability Index, and regularly ranks as the most transparent company for sustainability disclosure in the S&P 500. Beyond Newcrest’s well-established sustainability credentials and top quartile industry ranking, Newmont will apply its proven sustainability practices and leadership to Newcrest’s assets by:

  • Bringing a clear focus on mitigating safety risks along with visible, felt leadership in the field to drive a fatality-free business

  • Building on Newmont’s sustainability leadership and commitment to meaningful social engagement based on inclusion, transparency and integrity in order to be the partner of choice for governments, host communities, suppliers and workforce

  • Remaining committed to Newmont’s leading environmental stewardship practices and climate goals

  • Creating a diverse, inclusive and equitable workplace where everyone is welcome, attracting and retaining the breadth of skills and innovation needed to continuously improve performance

World-Class Portfolio

This acquisition would create a world-class portfolio of assets with the highest concentration of Tier 1 operations, primarily in favorable, low-risk mining jurisdictions. Supported by this portfolio, Newmont will be well-positioned to generate strong, stable and lasting returns with best-in-class sustainability performance, well into the future.

Through the combination of high-quality operations, projects and reserves, this portfolio is expected to deliver:

  • Outstanding depth and breadth of global production focused across stable mining jurisdictions:8

    • Approximately 8 million ounces of total combined annual gold production upon closing the Transaction, with more than 5 million gold ounces, or two-thirds of total gold production, from 10 large, long-life, low cost, Tier 1 assets

    • Combined annual copper production of approximately 350 million pounds from Australia and Canada

  • An extensive portfolio of greenfield and brownfield growth options from the industry’s largest reserve and resource base:

    • 96 million ounces of gold reserves declared by Newmont and 52 million ounces declared by Newcrest, along with 111 million and 68 million ounces of gold resources, respectively9
    • Significant majority of combined entity’s gold reserves will be located in the Americas and Australia

    • Value-generating projects across some of the world’s most prospective regions including Canada’s Golden Triangle

  • Meaningful increase in copper reserves, a critical metal in facilitating the transition to a new energy economy

  • Maintaining a disciplined approach to mine planning and project development at reserve gold pricing, creating a resilient business to maximize long-term returns

Delivering Synergies

The combined business would be immediately supported by Newmont’s scalable, integrated operating model with a deep bench of experienced leaders, subject matter experts and existing regional teams in Australia and Canada. Building on the experience gained following the acquisition of Goldcorp, Newmont has identified the opportunity for substantial synergies:

  • $500 million of total annual pre-tax synergies anticipated to be achieved within the first 24 months following the completion of the Transaction:

    • Approximately $100 million of pre-tax general and administrative synergies driven by Newmont’s scalable, integrated operating model with existing regional teams in Australia and Canada

    • Approximately $200 million of supply chain synergies from best-in-class pricing and existing strong partnerships with key suppliers, smelters and equipment manufacturers through unprecedented economies of scale

    • At least $200 million of benefits from Newmont’s proven Full Potential continuous improvement program, which improves costs and productivity through the rapid replication of leading processes and advanced technology10

Further value creation opportunities are anticipated as the Newcrest portfolio is fully integrated into Newmont, bringing together the industry’s best talent and processes across two key mining jurisdictions, including, among other things, the benefits from the experience of Newcrest’s world-class block caving team.

Australia

The Transaction brings together two of Australia’s largest gold producers and would reinforce Newmont’s long-standing commitment to safe, profitable and responsible gold and copper production in the country for decades to come.

Newmont will leverage its existing regional operating model in Australia and, following the Transaction, will combine and optimize both companies’ leaders, subject matter experts, supply chains and regional infrastructure to drive best-in-class performance.

Newmont intends to apply for a foreign exempt listing on the Australian Securities Exchange (“ASX”) and establish Clearing House Electronic Sub-register System Depositary Interests (“CDIs”) on the ASX. Newcrest shareholders may elect to receive CDIs representing a unit of beneficial ownership in Newmont common stock based on their country of residence.

Papua New Guinea

Upon closing of the Transaction, Newmont will establish a regional presence and in-country offices in Papua New Guinea, committed to building and maintaining strong, proactive and mutually beneficial relationships with host governments and local communities while supporting safe and profitable operations.

Canada

Once complete, the Transaction will solidify Newmont’s position in Canada through the combination of operating mines and development projects, creating a Tier 1 district in British Columbia’s highly-prospective Golden Triangle.

The combination will also leverage Newmont’s existing regional operating model in North America to combine and optimize both company’s leaders, subject matter experts, supply chains and regional infrastructure to drive best-in-class performance.

Looking ahead, the Company’s expanded footprint in Canada, together with shared ore body experience and technical expertise, could unlock gold and copper opportunities from the combined organic project pipeline, including the key projects Galore Creek and Saddle North.

Newmont will maintain its current listing on the TSX following closing of the Transaction.

Driving Capital Allocation

Newmont remains committed to its capital allocation strategy, which starts with maintaining an investment grade balance sheet with strength and flexibility. The combined company’s balance sheet will be supported by an even stronger, lower cost, diversified portfolio focused in low-risk mining jurisdictions. With the sector’s largest reserve and resource base, the combined business will be in a very strong position to advance the most value-accretive development opportunities and sustainably improve overall shareholder returns.

The Transaction is highly accretive to Newmont shareholders which is further improved when anticipated synergies are fully realized within the first 24 months of closing. Additionally, Newmont intends to enhance cash flow by at least $2 billion in the first two years after closing through portfolio optimization.

Newmont will remain committed to maintaining its industry-leading dividend framework with a robust platform to drive leading returns throughout the price cycle:11

  • $1.00 per share at reserve pricing assumption of $1,400/oz

  • Variable component is calibrated in gold price increments of $300 per ounce

  • Variable component is assessed annually in alignment with the business planning cycle, considering the current macroeconomic environment and the current level of reinvestment in the business

  • Supported by strong and flexible investment-grade balance sheet

  • Dividend payouts are reviewed and approved quarterly by Newmont’s Board of Directors

TRANSACTION SUMMARY AND CLOSE TIMELINE

  • Under the terms of the Scheme, Newmont will acquire all outstanding Newcrest shares and Newcrest shareholders will receive 0.400 Newmont shares (or 0.400 Newmont CDIs) for each Newcrest share held

  • Newcrest will also fund and pay to its shareholders a franked special dividend of up to USD$1.10 per Newcrest share, conditional on the Scheme becoming effective

  • Under the terms of the Scheme, and based on current market prices, the implied equity value of Newcrest is A$26.2 billion, including the dividend, with an enterprise value of A$28.8 billion

  • Upon implementation of the Scheme, Newmont and Newcrest shareholders will own approximately 69 percent and 31 percent of the combined entity, respectively

  • The Scheme is subject to customary conditions including:

    • Shareholder approvals from both companies

      • Newcrest: more than 50 percent of shareholders voting and at least 75 percent of votes cast

      • Newmont: more than 50 percent of votes cast

    • The Independent Expert concluding that the Scheme is in the best interests of Newcrest shareholders

    • Relevant regulatory approvals

    • No material adverse event or prescribed occurrences in respect of either company

  • Newcrest and Newmont are each subject to customary exclusivity restrictions, including no-shop, no-talk, and no diligence restrictions, subject to certain customary exceptions

  • The SID contemplates a break/termination fee (payable by Newcrest) and a reverse break/termination fee (payable by Newmont) in certain circumstances, with the quantum of each determined by reference to 1 percent of the equity value of the corresponding party (with a discounted amount of the reverse break fee payable, only to reimburse Newcrest for its third party costs, if Newmont stockholder approval is not ultimately obtained)

  • Newmont intends to apply for a foreign exempt listing and establish CDIs on the ASX with respect to Newmont shares issued to Newcrest shareholders

  • The Transaction is expected to close in the fourth quarter of 2023

GOVERNANCE

Gregory Boyce will continue as Chair of Newmont’s Board of Directors (“Board”) and the Board will select two directors from Newcrest to join the Newmont Board. Tom Palmer will continue as President and Chief Executive Officer of Newmont and will lead the combined company with a focus on safely and responsibly leading the combined workforce, integrating the acquired assets and delivering on shareholder commitments.

________________________________________________

1 Clearing House Electronic Sub-register System Depositary Interests representing a unit of beneficial ownership in a share of Newmont common stock.

2 Premium analysis calculated by reference to the exchange ratio of 0.400x shares of Newmont for each Newcrest share held and a special dividend of up to USD$1.10 per Newcrest share. Share prices based on NYSE and ASX trading of Newmont and Newcrest shares, respectively, as at close of February 3, 2023.

3 See endnote G regarding Tier 1 assets

4 See endnote A regarding pre-tax synergies.

5 See endnote B regarding portfolio optimization.

6 Recommendation in the absence of a superior proposal emerging.

7 Amounts presented on an attributable basis. Reserves and resources data for Newcrest are historical reserves estimates as at June 30, 2022, sourced from Newcrest’s company Annual Mineral Resources and Ore Reserves Statement, dated August 19, 2022. Newmont has been unable to update, and does not expect to be able to update, the Newcrest historical reserves estimates, prior to the completion of the Transaction. Accordingly, Newmont is not treating these historical estimates as current estimates of mineral resources or mineral reserves because a qualified person (as defined under SEC standards) has not done sufficient work to classify the estimate as a current estimate of mineral resources or mineral reserves. See endnote F.

8 See endnote C regarding past performance. Amounts presented on an attributable basis of 6.0 million ounces of gold production for Newmont’s year ended December 31, 2022 and 2.0 million ounces of gold production for Newcrest’s year ended June 30, 2022, from respective company filings.

9 See footnote 7 above and endnote F below.

10 See endnote D regarding Full Potential improvements.

11 Expectations regarding 2023 dividend levels are forward-looking statements. See endnote E regarding our dividend framework.

Readers are reminded to refer to the endnotes to this press release for additional information.

ANALYST AND INVESTOR WEBCAST AND CONFERENCE CALL

Newmont – Business Update

May 15, 2023 at 8 a.m. Eastern Daylight Time (10 p.m. Australian Eastern Standard Time)

Conference Call Details

 

Dial-In Number

833.470.1428

Intl Dial-In Number

404.975.483912

Dial-in Access Code

984641

Conference Name

Newmont

Replay Number

866.813.9403

Replay Access Code

375213

Webcast Details

Title: Newmont – Business Update

URL: https://events.q4inc.com/attendee/420915744

The webcast materials will be available before the conference call on the “Investor Relations” section of the Company’s website, www.newmont.com. Additionally, the conference call will be archived for a limited time on the Company’s website.

ADVISORS AND COUNSEL

In connection with the Transaction, Newmont has engaged BofA Securities, Centerview Partners LLC, Lazard and BMO Capital Markets as its financial advisers, and King & Wood Mallesons and White & Case LLP as its legal advisers. Mackenzie Partners, Inc. will act as proxy solicitation agent.

ABOUT NEWMONT

Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.

________________________________________________

12 For a full list of toll-free phone numbers, refer to the following link: https://www.netroadshow.com/events/global-numbers?confId=51039

Readers are reminded to refer to the endnotes to this press release for additional information.

At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com.

Additional Information about the Transaction and Where to Find It

This press release is not an offer to purchase or exchange, nor a solicitation of an offer to sell securities of Newmont or Newcrest nor the solicitation of any vote or approval in any jurisdiction nor shall there be any such issuance or transfer of securities of Newmont or Newcrest in any jurisdiction in contravention of applicable law. This press release is being made in respect of the transaction involving Newmont and Newcrest pursuant to the terms of a scheme implementation deed dated May 14, 2023 (the “Scheme Implementation Deed”) by and among Newmont, Newmont Overseas Holdings Pty Ltd, an Australian proprietary company limited by shares, an indirect wholly owned subsidiary of Newmont, and Newcrest and may be deemed to be soliciting material relating to the transaction. In furtherance of the pending transaction and subject to future developments, Newmont will file one or more proxy statements or other documents with the Securities and Exchange Commission (“SEC”). This press release is not a substitute for any proxy statement, the Scheme Booklet or other document Newmont or Newcrest may file with the SEC and Australian regulators in connection with the pending transaction. INVESTORS AND SECURITY HOLDERS OF NEWMONT AND NEWCREST ARE URGED TO READ THE PROXY STATEMENT(S), SCHEME BOOKLET AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE TRANSACTION AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PENDING TRANSACTION AND THE PARTIES TO THE TRANSACTION. The definitive proxy statement will be mailed to Newmont stockholders. Investors and security holders may obtain a free copy of the proxy statements, the filings with the SEC that will be incorporated by reference into the proxy statement, the Scheme Booklet and other documents containing important information about the transaction and the parties to the transaction, filed by Newmont with the SEC at the SEC’s website at www.sec.gov. The disclosure documents and other documents that are filed with the SEC by Newmont may also be obtained on https://www.newmont.com/investors/reports-and-filings/default.aspx or by contacting Newmont’s Investor Relations department at [email protected] or by calling 303-837-5484.

Participants in the Transaction Solicitation

Newmont, Newcrest and certain of their respective directors and executive officers and other employees may be deemed to be participants in any solicitation of proxies from Newmont shareholders in respect of the pending transaction between Newmont and Newcrest. Information regarding Newmont’s directors and executive officers is available in its Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 23, 2023 and its proxy statement for its 2023 Annual Meeting of Stockholders, which was filed with the SEC on March 10, 2023. Information about Newcrest’s directors and executive officers is set forth in Newcrest’s latest annual report dated August 19, 2022 as updated from time to time via announcements made by Newcrest on the Australian Securities Exchange. Additional information regarding the interests of these participants in such proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in any proxy statement and other relevant materials to be filed with the SEC in connection with the pending transaction if and when they become available.

Cautionary Statement Regarding Forward-Looking Statements

This press release, and the exhibits hereto, contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor created by such sections and other applicable laws and “forward-looking information” within the meaning of applicable Australian securities laws. Where a forward-looking statement expresses or implies an expectation or belief as to future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. However, such statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by the forward-looking statements. Forward-looking statements often address our expected future business and financial performance and financial condition; and often contain words such as “anticipate,” “intend,” “plan,” “will,” “would,” “estimate,” “expect,” “believe,” “target,” “indicative,” “pending,” “preliminary,” “proposed” or “potential.” Forward-looking statements may include, without limitation, statements relating to (i) the pending transaction to acquire the share capital of Newcrest, the expected terms, timing and closing of the pending transaction, including receipt of required approvals and satisfaction of other customary closing conditions; (ii) estimates of future production, including expected annual production range; (iii) estimates of future costs applicable to sales and all-in sustaining costs; (iv) estimates of future cash flow enhancements through portfolio optimization, cost reductions, synergies, including pre-tax synergies, savings and efficiencies; (v) expectations regarding future exploration and the development, growth and potential of Newmont’s and Newcrest’s operations, project pipeline and investments; (vi) expectations regarding future investments or divestitures, including anticipated divestitures over the next two years; (vii) expected listing of common stock on the New York Stock Exchange, the Toronto Stock Exchange and the Australian Securities Exchange; and (viii) expectations from the integration of Newcrest, including the combined company’s production capacity, asset quality and geographic spread. Estimates or expectations of future events or results are based upon certain assumptions, which may prove to be incorrect. Such assumptions, include, but are not limited to: (i) there being no significant change to current geotechnical, metallurgical, hydrological and other physical conditions; (ii) permitting, development, operations and expansion of Newmont’s and Newcrest’s operations and projects being consistent with current expectations and mine plans, including without limitation receipt of export approvals; (iii) political developments in any jurisdiction in which Newmont and Newcrest operate being consistent with its current expectations; (iv) certain exchange rate assumptions for the Australian dollar to the U.S. dollar, as well as other the exchange rates being approximately consistent with current levels; (v) certain price assumptions for gold, copper, silver, lead and oil; (vi) prices for key supplies being approximately consistent with current levels; (vii) the accuracy of current mineral reserve, mineral resource and mineralized material estimates; and (viii) other planning assumptions. Risks relating to forward looking statements in regard to the Company’s business and future performance may include, but are not limited to, gold and other metals price volatility, currency fluctuations, operational risks, increased production costs and variances in ore grade or recovery rates from those assumed in mining plans, political risk, community relations, conflict resolution, governmental regulation and judicial outcomes and other risks. In addition, material risks that could cause actual results to differ from forward-looking statements include: the inherent uncertainty associated with financial or other projections; the prompt and effective integration of Newmont’s and Newcrest’s businesses and the ability to achieve the anticipated synergies and value-creation contemplated by the pending transaction; the risk associated with Newmont’s and Newcrest’s ability to obtain the approval of the pending transaction by their shareholders required to consummate the pending transaction and the timing of the closing of the pending transaction, including the risk that the conditions to the pending transaction are not satisfied on a timely basis or at all and the failure of the pending transaction to close for any other reason; the risk that a consent or authorization that may be required for the pending transaction is not obtained or is obtained subject to conditions that are not anticipated; the outcome of any legal proceedings that may be instituted against the parties and others related to the Scheme Implementation Deed; unanticipated difficulties or expenditures relating to the pending transaction, the response of business partners and retention as a result of the announcement and pendency of the transaction; risks relating to the value of the Scheme Consideration to be issued in connection with the pending transaction; the anticipated size of the markets and continued demand for Newmont’s and Newcrest’s resources and the impact of competitive responses to the announcement of the transaction; and the diversion of management time on pending transaction-related issues. For a more detailed discussion of such risks and other factors, see Newmont’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC as well as the Company’s other SEC filings, available on the SEC website or www.newmont.com. Newcrest’s most recent annual report for the fiscal year ended June 30, 2022 as well as Newcrest’s other filings made with Australian securities regulatory authorities are available on ASIC or www.newcrest.com. Newmont is not affirming or adopting any statements or reports attributed to Newcrest (including prior mineral reserve and resource declaration) in this press release or made by Newcrest outside of this press release. Newcrest is not affirming or adopting any statements or reports attributed to Newmont (including prior mineral reserve and resource declaration) in this press release or made by Newmont outside of this press release. Newmont and Newcrest do not undertake any obligation to release publicly revisions to any “forward-looking statement,” including, without limitation, outlook, to reflect events or circumstances after the date of this press release, or to reflect the occurrence of unanticipated events, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued “forward-looking statement” constitutes a reaffirmation of that statement. Continued reliance on “forward-looking statements” is at investors’ own risk.

Notice Regarding Reserves and Resources:

Unless otherwise stated herein, the reserves stated in this release represent estimates at December 31, 2022, which could be economically and legally extracted or produced at the time of the reserve determination. Estimates of proven and probable reserves are subject to considerable uncertainty. Such estimates are, or will be, to a large extent, based on metal prices and interpretations of geologic data obtained from drill holes and other exploration techniques, which data may not necessarily be indicative of future results. Additionally, resource does not indicate proven and probable reserves as defined by the SEC or the Company’s standards. Estimates of measured, indicated and inferred resource are subject to further exploration and development, and are, therefore, subject to considerable uncertainty. Inferred resources, in particular, have a great amount of uncertainty as to their existence and their economic and legal feasibility. The Company cannot be certain that any part or parts of the resource will ever be converted into reserves. For additional information on our reserves and resources, please see Item 2 of the Company’s Form 10-K, filed on February 23, 2023 with the SEC.

See endnote F below regarding estimates of Newcrest’s reserves and resources.

Endnotes

 

 

A.

Synergies. Synergies and value creation as used in this press release is a management estimate provided for illustrative purposes and should not be considered a GAAP or non-GAAP financial measure. Synergies represent management’s combined estimate of pre-tax synergies, supply chain efficiencies and Full Potential improvements, as a result of the integration of Newmont’s and Newcrest’s businesses that have been monetized for the purposes of the estimation. Because synergy estimates reflect differences between certain actual costs incurred and management estimates of costs that would have been incurred in the absence of the integration of Newmont’s and Newcrest’s businesses, such estimates are necessarily imprecise and are based on numerous judgments and assumptions. Synergies are “forward-looking statements” subject to risks, uncertainties and other factors which could cause actual value creation to differ from expected or past synergies.

B.

Portfolio Optimization. Portfolio optimization as used in this press release is a management estimate provided for illustrative purposes and should not be considered a GAAP or non-GAAP financial measure. Because the enhancement to cash flow estimates the differences between certain actual cash flows and management estimates of cash flows in the absence of the integration of Newmont’s and Newcrest’s businesses, such estimates are necessarily imprecise and are based on numerous judgments and assumptions. Portfolio optimization to enhance cash flows is a “forward-looking statement” subject to risks, uncertainties and other factors which could cause enhanced cash flows to differ from expectations.

C.

Past Performance. Past performance metrics and figures included in this presentation are given for illustrative purposes only and should not be relied upon as (and are not) an indication of Newmont’s views on its or Newcrest’s future production, financial performance or condition or prospects (including on a consolidated basis). Investors should note that past performance of Newmont, including in relation to the past value returned to stockholders and past value creation and annual synergies, and other historical financial information cannot be relied upon as an indicator of (and provide no guidance, assurance or guarantee as to) future production or performance.

D. Full Potential. Full Potential improvement value creation is considered an operating measure provided for illustrative purposes, and should not be considered GAAP or non-GAAP financial measures. Full Potential amounts are estimates utilized by management that represent estimated cumulative incremental value realized as a result of Full Potential projects implemented and are based upon both cost savings and efficiencies that have been monetized for purposes of the estimation. Because Full Potential improvement estimates reflect differences between certain actual costs incurred and management estimates of costs that would have been incurred in the absence of the Full Potential program, such estimates are necessarily imprecise and are based on numerous judgments and assumptions. Expectations of the results of Full Potential savings, synergies or improvements are forward-looking statements and subject to risks and uncertainties.
 

E.

Dividend. Our future dividends have not yet been approved or declared by the Board of Directors. An annualized dividend payout level has not been declared by the Board and is non-binding. The Company’s dividend framework and expected 2023 dividend payout ranges are non-binding. Management’s expectations with respect to future dividends, annualized dividends, payout ranges or dividend yield are “forward-looking statements.” The declaration and payment of future dividends remain at the discretion of the Board of Directors and will be determined based on Newmont’s financial results, balance sheet strength, cash and liquidity requirements, future prospects, gold and commodity prices, and other factors deemed relevant by the Board. The duration, scope and impact of COVID-19 presents additional uncertainties with respect to future dividends and no assurance is being provided that the Company will pay future dividends at the increased payment level. The Board of Directors reserves all powers related to the declaration and payment of dividends. Consequently, in determining the dividend to be declared and paid on the common stock of the Company, the Board of Directors may revise or terminate the payment level at any time without prior notice.

F.

Cautionary Statement Regarding the Newcrest Historical Reserves Estimates: The mineral resource and mineral reserve estimates stated herein with respect to Newcrest (the “Newcrest Historical Reserves Estimates”) were prepared to meet the reporting requirements of the Australian Securities Exchange (“ASX”) Listing Rules Chapter 5, December 2019; the Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves, December 2012 (“JORC Code”), and were prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) of the Canadian Securities Administrators, June 2011, Canadian Institute of Mining, Metallurgy and Petroleum Definition Standards on Mineral Resources and Mineral Reserves, May 2014 and the rules of the Toronto Stock Exchange (“TSX”). Investors should note that the requirements of the JORC Code and NI 43-101 differ from the requirements of Subpart 1300 of Regulation S-K. Reserves and resources prepared under the JORC Code and NI-43-101 are normally not permitted to be used in reports and registration statements filed with the SEC. Certain of the Newcrest Historical Reserves Estimates include inferred resources, which would not be permitted under Subpart 1300 of Regulation S-K. Inferred resources involve a great amount of uncertainty as to their existence and their economic and legal feasibility. A significant amount of exploration must be completed in order to determine whether an inferred resource may be upgraded to a higher category. US investors are cautioned not to assume that all or any part of an inferred resource exists or is economically or legally mineable. Accordingly, there is no assurance that the Newcrest Historical Reserves Estimates or any other mineral reserves or mineral resources that Newcrest may report under JORC or NI 43-101 will be the same as the mineral reserve or mineral resource estimates prepared under Subpart 1300 of Regulation S-K. The Newcrest Historical Reserves Estimates are subject to review and adjustment following closing of the pending Transaction, in accordance with Subpart 1300 of Regulation S-K adopted by the SEC, including to meet required study levels, price assumptions, for future divestments and acquisitions and other factors. No assurances can be made that all historical Newcrest mineral reserves or mineral resources will be recognized as Newmont mineral reserves or mineral resources. Under Subpart 1300 of Regulation S-K, a registrant’s disclosure of exploration results, mineral resources or mineral reserves must be based on and accurately reflect information and supporting documentation prepared by a qualified person. Newmont has not been involved in the preparation of Newcrest’s historical mining reserve or mining resource estimates. Accordingly, Newmont assumes no responsibility for such estimates. Expectations regarding future reserves and resource declarations should be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor created by such sections and other applicable laws.

G.

Tier 1 Asset. Defined as +500k GEOs/year consolidated, average AISC/oz in the lower half of the industry cost curve and a mine life >10 years in countries that are classified in the A and B rating ranges for each of Moody’s, S&P and Fitch.

H.

Gold equivalent ounces (GEOs). Calculated as pounds or ounces produced multiplied by the ratio of the other metal’s price to the gold price, using Gold ($1,400/oz.), Copper ($3.50/lb.), Silver ($20/oz.), Lead ($1.00/lb.), and Zinc ($1.20/lb.) pricing.

 

Media Contact

Omar Jabara

720.212.9651

[email protected]

Investor Contact

Daniel Horton

303.837.5468

[email protected]

KEYWORDS: Colorado North America United States Australia Australia/Oceania Canada

INDUSTRY KEYWORDS: Mining/Minerals Natural Resources

MEDIA:

Logo
Logo

Sky Harbour Group Corporation Announces its 2023 Q1 Financial Results, Update on Leasing Activities and the Closing of its Acquisition of RapidBuilt

Sky Harbour Group Corporation Announces its 2023 Q1 Financial Results, Update on Leasing Activities and the Closing of its Acquisition of RapidBuilt

WEST HARRISON, N.Y.–(BUSINESS WIRE)–
Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home-Basing Solutions for business aircraft, announced the release of its 2023 1st quarter Financial Results in Form 10-Q. Please see the following link to access the filing:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001823587/000143774923014229/ysac20230331_10q.htm

Highlights of the results and other recent events are:

  • Q1 2023 Revenues increased 179% as compared to Q1 2022 and 82% compared to Q4 2022

  • S,G&A expenses decreased 23% compared to Q1 2022

  • Strong liquidity and capital resources as of March 31, 2023, including cash, restricted cash, and US Treasury investments of over $165 million

  • Closed the Project Modification and recapitalization of wholly owned Sky Harbour Capital, with a significant increase in the already robust projected debt service coverage of the Series 2021 Bonds1
  • New executed hangar tenant lease rents reach record mid-$40s per square foot

  • Houston, Nashville and Miami facilities are 94%, 64% and 67% leased, respectively, as of May 12, 2023. Full occupancy projected to be reached by end of Q3 2023.

On May 12, 2023, the Company exercised its option to acquire a controlling stake in Overflow LP, owner of Rapidbuilt Inc. (“RapidBuilt”), a Texas based manufacturer of pre-engineered metal buildings (PEMB). The Company previously executed a strategic supply agreement with RapidBuilt in July 2022 to guarantee production capacity and achieve optimum manufacturing margin for its hangar construction projects. With the closing of this acquisition, the Company believes that the vertical integration will enable it to deliver hangar buildings to each of the Company’s development sites in shorter timeframes, reducing the overall construction cost and duration of each of its projects. The Company paid nominal consideration for its initial 51% equity stake and agreed to assume its senior loan obligations of approximately $10 million. This acquisition is intended to be accretive to SKYH through immediate projected construction and operational savings. The 8-K filing related to this closing may be found on the link below:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001823587/000143774923014241/ysac20230511_8k.htm

Tal Keinan, Chairman and Chief Executive Officer, commented on the Q1 results and other recent events: “After operating its pilot campus in Houston for more than a year, Sky Harbour quickly grew to conducting full flight operations on three campuses, Nashville having opened in November 2022 and Miami in February 2023. As leasing nears completion, tenant feedback has been outstanding. Sky Harbour has taken a meaningful step forward in establishing its Home Basing Solution as the solution of choice for the country’s top aircraft owners.”

“The company’s attention is now increasingly focused on expanding Sky Harbour’s national footprint, continuing to refine Sky Harbour’s already unmatched service offering, and maximizing the economies of scale afforded by the Sky Harbour model.”

“As part of this effort, we are happy to welcome the RapidBuilt team into the Sky Harbour family. Vertical integration will produce considerable development cost advantages. More importantly, RapidBuilt brings the best engineering talent we have ever encountered in the Aviation PEMB and hangar-door spaces into the Sky Harbour prototyping process, yielding a constantly improving hangar, with outstanding quality consistency and a more efficient construction cycle.”

Sky Harbour campuses are open and operating at Houston’s Sugar Land Regional Airport (“SGR”), Nashville International Airport (“BNA”) and Miami Opa-Locka Executive Airport (“OPF”). Sky Harbour is developing new campuses at Denver Centennial Airport (“APA”) and Phoenix Deer Valley Airport (“DVT”), both of which are in construction, and Dallas Addison Airport (“ADS”), which is in permitting.

About Sky Harbour Group Corporation

Sky Harbour Group Corporation is an aviation infrastructure company developing the first nationwide network of Home-Basing Solutions for business aircraft. The company develops, leases and manages general aviation hangars across the United States. Sky Harbour’s Home-Basing Solution aims to provide private and corporate customers with the best physical infrastructure in business aviation, coupled with dedicated service tailored to based aircraft, offering the shortest time to wheels-up in business aviation. To learn more, visit www.skyharbour.group.

Forward Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements about the financial condition, results of operations, earnings outlook and prospects of SHG may include statements for the period following the consummation of the business combination. When used in this press release, the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management of SHG as applicable and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those discussed and identified in the public filings made or to be made with the SEC by SHG, including the filings described above, regarding the following: expectations regarding SHG’s strategies and future financial performance, including its future business plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and SHG’s ability to invest in growth initiatives; SHG’s ability to scale and build the hangars currently under development or planned in a timely and cost-effective manner; the implementation, market acceptance and success of SHG’s business model and growth strategy; the success or profitability of SHG’s hangar facilities; SHG’s future capital requirements and sources and uses of cash; SHG’s ability to obtain funding for its operations and future growth; developments and projections relating to SHG’s competitors and industry; the ability to recognize the anticipated benefits of the business combination; geopolitical risk and changes in applicable laws or regulations; the possibility that SHG may be adversely affected by other economic, business, and/or competitive factors; operational risk; risk that the COVID-19 pandemic, and local, state, and federal responses to addressing the pandemic may have an adverse effect on SHG’s business operations, as well as SHG’s financial condition and results of operations. Should one or more of these risks or uncertainties materialize or should any of the assumptions made by the management of SHG prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. SHG undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

1 Please see press release dated March 28, 2023 and related SEC filing.

Investor Relations:

[email protected]

Attn: Francisco X. Gonzalez, CFO

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property Air Transport Aerospace Manufacturing Transportation Other Construction & Property Travel

MEDIA:

Logo
Logo

FOX News Books to Release “Unbroken Bonds of Battle” by Retired Staff Sergeant Johnny Joey Jones on June 27th

FOX News Books to Release “Unbroken Bonds of Battle” by Retired Staff Sergeant Johnny Joey Jones on June 27th

“Unbroken Bonds of Battle: A Modern Warriors Book of Heroism, Patriotism and Friendship” Marks the Seventh Title for FOX News Books

NEW YORK–(BUSINESS WIRE)–
FOX News Books, FOX News Media’s publishing imprint, will release its seventh title on Tuesday, June 27th, “Unbroken Bonds of Battle,” by FOX News Channel (FNC) contributor, FOX Nation host and combat veteran Johnny Joey Jones. The book follows the Modern Warriors franchise debut title “Modern Warriors: Real Stories from Real Heroes” authored by FOX & Friends Weekend co-host and veteranPete Hegseth, which was a New York Times bestseller.

In commenting on the announcement, Jones remarked, “For years people have asked me to write a book about ‘my story.’ However, I’ve always known all along that the most important part of my story is the amazing collection of people and warriors who’ve become a part of my life. Each of them with inspiring and heroic stories of their own. It’s fitting that my first book is a telling of their stories, how they’ve affected my life and how their experience in serving this country shows the need for bonds on and beyond the battlefield. Unbroken Bonds is a book for, by and about patriotic Americans and what it truly means to be your brothers’ keeper.”

“Unbroken Bonds of Battle” marks the second installment of the growing Modern Warriors franchise, which spotlights those who have dedicated their lives to protecting the freedoms and the people of the United States of America. Staff Sergeant Jones served eight years in the Marine Corps with tours in Iraq and Afghanistan before an IED ended his career as a bomb technician, forever changing his life. Through the support of his brothers and sisters in arms, he began the arduous recovery and has since dedicated himself to paying it forward, working on behalf and with veterans for more than a decade. Featuring unfiltered and authentic conversations from across all branches of the military, Jones honors the true American heroes that not only defend this great nation, but protect their fellow warriors. With powerful lessons woven throughout these personal oral histories, along with a scrapbook of candid photos and an exploration of life, loss and even hunting, “Unbroken Bonds of Battle” will serve as a patriotic tribute to the tightknit community bonds built upon of faith, family and service.

Since the installment of FOX News Books, the publishing imprint has sold nearly 2 million copies, with each title placing on numerous national bestseller lists. The imprint launched in November 2020 with Hegseth’s “Modern Warriors: Real Stories from Real Heroes,” followed by Shannon Bream’s “The Women of the Bible Speak” (March 2021), “All American Christmas” by Rachel Campos-Duffy and Sean Duffy (November 2021), “The Mothers and Daughters of the Bible Speak” (March 2022), “Faith Still Move Mountains” by Harris Faulkner (October 2022) and most recently, “The Love Stories of the Bible Speak” (March 2023). Notably, every single FOX News Books title has made the New York Times bestsellers list, with Bream’s highly successful biblical “Speak” series, selling more than 1 million copies since launching in March 2021.

A FOX News Media contributor since 2019, Jones provides military and political analysis across all platforms including FOX News Channel, FOX Business Network (FBN), FOX News Audio and FOX Nation. He frequently serves as a co-host for FNC’s weekend programming, including The Big Saturday and The Big Sunday Show, as well as a substitute hosts across daytime and primetime programming. On FOX Nation, Jones has hosted several programs, including FOX Nation Outdoors, USA Ink, and Alive Day, a documentary dedicated to the harrowing day of his tragic accident and celebration of the life he was given after the explosion.

FOX News Media operates the FOX News Channel (FNC), FOX Business Network (FBN), FOX News Digital, FOX News Audio, FOX News Books, the direct-to-consumer streaming services FOX Nation and FOX News International and the free ad-supported television service FOX Weather. Currently the number one network in all of cable, FNC has also been the most watched television news channel for more than 21 consecutive years, while FBN is the top business channel on cable. Owned by Fox Corporation, FOX News Media reaches nearly 200 million people each month.

FOX News Media Contact:

Alexandra Coscia: 212.301.3272

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Women Publishing Men Communications General Entertainment Consumer Books Entertainment

MEDIA:

Logo
Logo

Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process

To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings

Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations 
and Fulfill APD Customer Orders During Process

BUFFALO, N.Y., May 14, 2023 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX) (“Athenex” or the “Company”), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that, following an ongoing strategic review, it has reached agreement with its lenders to move forward with an expedited sales process of the Company’s assets across its primary businesses: Athenex Pharmaceutical Division (“APD”), Orascovery, and Cell Therapy.

To best facilitate this process, Athenex and certain of its subsidiaries filed voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. This will enable the Company to divest its assets and wind down the Athenex platform in an orderly fashion, while seeking to maximize value for its stakeholders. The Company anticipates concluding the expedited sales process by July 1, 2023, with the Chapter 11 cases continuing thereafter to resolve claims.

Athenex has also reached an agreement with its secured lenders, subject to court approval, for the consensual use of cash collateral, which will enable the Company to, among other things, satisfy certain obligations to its vendors for authorized goods received and services rendered after the filing. Athenex Pharma Solutions (“APS”), which includes the Company’s manufacturing facility in Clarence, New York, is expected to continue its operations for at least the next 90 days, to provide commercial supply of tirbanibulin ointment. In addition, APD is continuing to operate in the ordinary course and fill customer orders with the ample inventory it has on hand.

Dr. Johnson Lau, Chief Executive Officer of Athenex, on behalf of the management team and the Athenex Board of Directors, said, “Throughout our history, we have sought to become a leader in bringing innovative cancer treatments to the market and improving patient health outcomes. Our team was successful in bringing tirbanibulin, through regulatory approvals, to the U.S. market and a number of EU countries, as well as Taiwan. Unfortunately, our oral paclitaxel product candidate received a complete response letter from the U.S. Food and Drug Administration, and this significant regulatory setback, coupled with challenging biotech markets and the difficult economic environment, put tremendous pressure on our ability to continue to fund our businesses.

“Over the past two years, we made considerable progress in refocusing our business around our promising NKT cell therapy platform, monetizing non-core assets to improve our balance sheet and extending our cash runway, paying down $108 million of debt, and undertaking a comprehensive review of strategic alternatives to create value for our stakeholders. While we explored every viable avenue to avoid this outcome, an orderly sales process represents the best path forward at this time.

“Our goal remains to identify purchasers who will continue development of the important drug candidates for which we have established a good foundation, and to bring them to market on behalf of medical practitioners and, most importantly, for patients. We are incredibly thankful to our team for their dedication to Athenex and will look to support our colleagues through this transition period.”

Additional information regarding Athenex’s Chapter 11 filing is available at https://dm.epiq11.com/athenex; by calling the Company’s claims agent, Epiq, at 888-601-3094 (toll-free) or +1 503-433-8501 (international); or by sending an email to [email protected].

Pachulski Stang Ziehl & Jones LLP is acting as Athenex’s legal counsel. MERU is serving as its financial advisor and Cassel Salpeter & Co., LLC as its investment banker.

About Athenex, Inc.

Founded in 2003, Athenex, Inc. is a clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next-generation cell therapy products for the treatment of cancer. The Company’s mission is to become a leader in bringing innovative cancer treatments to the market and to improve patient health outcomes. In pursuit of this mission, Athenex leverages years of experience in research and development, clinical trials, regulatory standards, and manufacturing. The Company is focused on its innovative Cell Therapy platform, based on natural killer T (“NKT”) cells. For more information, please visit www.athenex.com.

Forward-Looking Statements

Except for historical information, information in this press release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that are difficult to predict. Words such as “anticipate,” “could,” “expect,” “may,” “seek,” “will,” and similar expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Actual results might differ materially from those explicit or implicit in the forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions including: risks inherent in the bankruptcy process, including the Company’s ability to obtain approval from the Bankruptcy Court for motions or other requests made throughout the course of the Chapter 11 proceedings; the Company’s liquidity and financial position; the effects of the Chapter 11 proceedings on the Company’s operations; the Company’s ability to continue to operate its business during the pendency of the Chapter 11 proceedings, and the availability of operating capital during the Chapter 11 proceedings; the Company’s ability to maintain relationships with partners, suppliers, customers, employees, regulatory authorities and other third parties; the length of time that the Company will operate under Chapter 11 protection; objections to the Company’s restructuring or liquidation process, third-party motions, or other pleadings filed that could protract the Chapter 11 proceedings; and Bankruptcy Court rulings in the Chapter 11 proceedings and the outcome of the Chapter 11 proceedings, in general. You should not rely upon forward-looking statements as predictions of future events. The Company undertakes no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in its expectations, except as required by law.

Investor Contacts

[email protected]

716.427.2952

Media Contacts

Daniel Yunger / Wendi Kopsick
Kekst CNC
[email protected] 



Ascendis Pharma Showcases Commitment to Rare Endocrine Diseases at the 25th European Congress of Endocrinology 2023

COPENHAGEN, Denmark, May 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced the company will present clinical and research outcomes in hypoparathyroidism and growth hormone deficiency, and host informational booth and events, at ECE 2023, the European Congress of Endocrinology being held May 13-16 in Istanbul, Turkey. ECE gathers international professionals to share the latest science and clinical practice across the fields of endocrinology and metabolism.

“Ascendis is committed to creating novel therapies with best-in-class safety, efficacy, tolerability, and convenience,” said Jan Mikkelsen, Ascendis Pharma’s President and Chief Executive Officer. “We are pleased to showcase our advancing Endocrinology portfolio, the meaningful differences we are making for patients, and our work to bring new treatment options to the European Union.”

Following are the five Ascendis Pharma posters at ECE 2023:

ABSTRACT

  PRESENTING AUTHOR
Hypoparathyroidism    
  • TransCon PTH Improves Health-Related Quality of Life and Reduces Work Limitations in Adults with Hypoparathyroidism: Patient-Reported Outcomes in the Phase 3 PaTHway Trial
  Christopher Sibley, M.D.

Poster
Display Date 14 May
Program code: P432
Session #969

  • Healthcare Resource Utilization Associated with Post-Surgical and Non-Surgical Chronic Hypoparathyroidism in England: A Linked Clinical Practice Research Datalink, Hospital Episode Statistics, and Office for National Statistics Retrospective Analysis
  Christopher Sibley, M.D.

Program code: P301
Display date:
15 May Poster
Session #986

Growth Hormone Deficiency    
  • Patient-Centric Design of the Lonapegsomatropin Auto-Injector for Pediatric Growth Hormone Deficiency
  Nils Berg Madsen, Ph.D.

e-Poster
Program code: EP745
Session #999

  • Design of the foresiGHt Trial: A Multicenter, Randomized, Placebo- and Active-Controlled Trial to Compare Once-Weekly Lonapegsomatropin to Placebo and Daily Somatropin in Adults with Growth Hormone Deficiency (GHD)
  Aleksandra Gilis-Januszewska, M.D., Ph.D.

Poster
Program code: P432
Display date: 15 May
Session #897

  • A Low Incidence of Transient Anti-Drug Antibodies Is Observed Upon Long-Term Exposure to Lonapegsomatropin in Children with Growth Hormone Deficiency
  Per Holse Mygind, Ph.D.

Poster
Program code: P702
Display date: 16 May
Session #975

     

About Ascendis Pharma A/S

Ascendis Pharma is applying its innovative TransCon technology platform to build a leading, fully integrated, global biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company uses its TransCon technologies to create new and potentially best-in-class therapies. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Germany (Heidelberg, Berlin and Munich) and the United States (Palo Alto and Redwood City, California, and Princeton, New Jersey). Visit ascendispharma.com to learn more.

Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis’ future operations, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, statements relating to (i) Ascendis’ ability to apply its TransCon technology platform to build a leading, fully integrated, global biopharma company, and (ii) Ascendis’ use of its TransCon technologies to create new and potentially best-in-class therapies. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including the following: dependence on third party manufacturers, distributors and service providers for Ascendis’ products and product candidates; unforeseen safety or efficacy results in its development programs or on-market products; unforeseen expenses related to commercialization of any approved Ascendis products; unforeseen expenses related to Ascendis’ development programs; unforeseen selling, general and administrative expenses, other research and development expenses and Ascendis’ business generally; delays in the development of its programs related to manufacturing, regulatory requirements, speed of patient recruitment or other unforeseen delays; Ascendis’ ability to obtain additional funding, if needed, to support its business activities; the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on its business from the worldwide COVID-19 pandemic and ongoing conflicts such as that in the region surrounding Ukraine and Russia. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis’ business in general, see Ascendis’ Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) on February 16, 2023 and Ascendis’ other future reports filed with, or submitted to, the SEC. Forward-looking statements do not reflect the potential impact of any future licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.

Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, and TransCon are trademarks owned by the Ascendis Pharma group. © May 2023 Ascendis Pharma A/S.

     

Investor Contacts:
 
Media Contact:
Tim Lee   Melinda Baker
Ascendis Pharma   Ascendis Pharma
+1 (650) 374-6343   +1 (650) 709-8875

[email protected]
 
[email protected]

[email protected]
   
     
Patti Bank    
ICR Westwicke    
+1 (415) 513-1284    

[email protected]
   

 



Coty Introduces Orveda Serum and Infiniment Coty Paris Fragrance as the Company Charts a New Course at Gala Event in Cannes

Coty Introduces Orveda Serum and Infiniment Coty Paris Fragrance as the Company Charts a New Course at Gala Event in Cannes

  • Coty unveils new OmniPotent Concentrate serum under ultra-premium skincare brand Orveda

  • Coty outlines plans for Infiniment Coty Paris, the future of niche fragrance

  • Together, these brands chart a new course for Coty fusing art, science, and sustainability

CANNES, France–(BUSINESS WIRE)–
Today, Coty Inc. (NYSE: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, skin and body care, announces the launch of an innovative new serum by ultra-premium skincare line Orveda and Infiniment Coty Paris, the Company’s most ambitious fragrance project to date.

On the eve of the Cannes Film Festival, at a gala launch event held at the renowned Villa Botanica attended by celebrities and beauty editors from around the world, Coty unveiled “Coty Protopia,” its vision for empowering bold and creative expressions of beauty. Rooted in Coty’s deep industry heritage, Coty Protopia represents a new approach to power beauty through cutting-edge innovation and science, underpinned by the Company’s commitment to sustainability and new art.

“At Coty, we firmly believe that no one can control or dictate what is, or is not, beautiful. The future of beauty we strive to create is one anchored in a deep respect for, and commitment to, infinite expressions of individual beauty and experiences,” said Sue Y. Nabi, Chief Executive Officer of Coty. “This ethos is embodied in our latest innovations, Orveda’s new Omnipotent Concentrate serum, which I believe is perhaps the most potent serum of all time. Infiniment Coty Paris, our most ambitious fragrance project to date, aims to usher in a new era for fragrances and perfumery, representing to fragrance what Orveda is to skincare.”

In her opening speech at the launch event, Sue Y. Nabi also celebrated Coty’s 30-year partnership with DKMS, one of the most significant non-profit organizations in the fight against blood cancer, as well as the largest stem cell donor center worldwide. Katharina Harf, DKMS global Chairman, spoke of the organization’s mission and ethos before sharing a moving film highlighting some of its critical projects and lifesaving initiatives, thanks in part to the support of Coty.

As part of the event to launch Orveda’s Omnipotent Concentrate serum and Infiniment Coty Paris, over 100 VIP guests were able to sample a selection of Orveda’s products and hear from the scientific and creative teams behind these two new innovations. Singer-songwriter LP also gave a special performance before guests enjoyed dinners that were specially curated by multi- Michelin starred chef Dominique Crenn.

Orveda

Founded in 2014, Orveda is a pioneer renowned for accelerating the microbiome and prebiotics science in skincare, with all products being vegan, sustainably-minded, and genderless.

“As part of our continued quest to power beauty with cutting-edge science, Orveda has created OmniPotent Concentrate, a new serum that sits at the crossroads of scientific innovation in the areas of microbiome and cellular longevity,” said Orveda CEO Nicolas Vu. “OmniPotent Concentrate has shown very strong clinical results and is expected to further cement Orveda’s leading position at the nexus of innovation, beauty, and wellness.”

Further highlighting the unique relationship between art, science, and sustainability, Orveda also announced a collaboration with the Azzedine Alaïa Foundation to sponsor aspiring fashion designers from across Africa and Asia. Established in 2007 by the iconic designer Azzedine Alaïa, the Azzedine Alaïa Foundation is committed to preserving and celebrating diverse works across the disciplines of art, fashion, and design. Coty’s collaboration with the Foundation will serve to disrupt mainstream, obsolete expressions of beauty on the global stage, and provide a new arena for underrepresented contemporary creatives to explore and unleash their unique perceptions of beauty.

Infiniment Coty Paris

Over nearly 120 years, Coty has evolved to become a leader in the fragrance industry, anchored by deep industry expertise, leading IP, as well as an iconic portfolio of signature fragrance brands. Further building on this position, Coty is pleased to unveil “Infiniment Coty Paris,” its most ambitious and most premium fragrance project to date.

Harnessing over a century of experience and some of the most creative talents in beauty, Infiniment Coty Paris will be to fragrance what Orveda is to skincare: a leading pioneer in the industry. The collection will ultimately include a range of fourteen diverse scents. It is expected to be launched globally in 2024 and is the first fragrance with patents pending for both the formulation and the packaging.

“Infiniment Coty Paris is a creation that marks a natural progression for the company, fusing beauty, science, and art,” said Nabi. “Today’s announcement is a small teaser of all that is to come in the coming months, when we unveil the full extent of this exciting project to consumers across the globe.”

In celebrating wide-ranging forms of modern beauty, Infiniment Coty Paris has partnered with the 1-54 Contemporary African Art Fair to showcase innovative works from artists across Africa. 1-54 is the first and only international art fair dedicated to highlighting contemporary art from Africa and its diaspora. Two of the works selected as part of the collaboration were displayed at the event at Villa Botanica.

About Coty Inc.

Founded in Paris in 1904, Coty is one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care. Coty serves consumers around the world, selling prestige and mass market products in more than 130 countries and territories. Coty and our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to making a positive impact on the planet. Learn more at coty.com or on LinkedIn and Instagram.

Aurélie Petit +336 01 33 05 53

[email protected]

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Luxury Other Retail Entertainment Specialty Events/Concerts Celebrity Film & Motion Pictures Cosmetics Retail

MEDIA:

Logo
Logo

Lowey Dannenberg P.C. Investigates Bowlero Corp. for Potential Violations of Securities Laws

NEW YORK, May 13, 2023 (GLOBE NEWSWIRE) — Lowey Dannenberg, P.C. a preeminent law firm in obtaining redress for investors, is investigating violations of securities laws and/or other business practices involving the directors and officers of Bowlero Corp. (“Bowlero” or the “Company”) (NYSE: BOWL).

If you are a purchaser of Bowlero common stock and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys at (914) 733-7256 or via email to Andrea Farah ([email protected]) or Radhika Gupta ([email protected]) to know more about this investigation.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact:

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email: [email protected]

SOURCE: Lowey Dannenberg



In Accordance with NYSE Rule 303A.08, this Press Release Makes Public the Grant of an Employment Inducement Award to Weave Communications’ New Chief Strategy & Services Officer

In Accordance with NYSE Rule 303A.08, this Press Release Makes Public the Grant of an Employment Inducement Award to Weave Communications’ New Chief Strategy & Services Officer

LEHI, Utah–(BUSINESS WIRE)–
As required by the rules of the New York Stock Exchange, Weave Communications, Inc. (NYSE: WEAV), a leading all-in-one customer communications and engagement software platform for small and medium-sized businesses, today announced that it has granted to Marcus Bertilson, Weave’s recently appointed Chief Strategy & Services Officer, on May 10, 2023, the following equity award as an inducement for him to accept employment: restricted stock units relating to 250,000 shares of Weave’s common stock, which vest over three years, with 33% vesting on June 15, 2024 and the remaining 67% over the following 2 years in equal quarterly installments, in each case subject to Mr. Bertilson’s continued service through each vesting date.

The employment inducement award was granted under Weave’s 2022 Inducement Equity Incentive Plan and related form of restricted stock unit agreement. The Compensation Committee of Weave’s Board of Directors approved this award in reliance on the employment inducement exception to shareholder approval provided under Section 303A.08 of the NYSE Listed Company Manual. To comply with the terms of this exemption, the employment inducement award requires prompt public announcement of the award and written notice to the NYSE.

About Weave

Weave is a leading all-in-one customer communication and engagement platform for small- and medium-sized businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire customer journey. Weave’s software solutions transform how local businesses attract, communicate with and engage customers to grow their business. Weave has set the bar for Utah startup achievement & work culture. In the past year, Weave has been named a G2 leader in Patient Engagement, Optometry, Dental Practice Management and Patient Relationship Management software. To learn more, visit getweave.com/newsroom/.

Investor Relations

Mark McReynolds

Head of Investor Relations

[email protected]

KEYWORDS: Utah United States North America

INDUSTRY KEYWORDS: Professional Services Small Business Technology Start-Up Telecommunications Software Networks

MEDIA:

Logo
Logo

Ero Copper Files Technical Report for the Xavantina Operations

VANCOUVER, British Columbia, May 12, 2023 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce the filing of its Technical Report for the Xavantina Operations related to the increase in mineral reserves and mineral resources and extension of mine life as previously announced on March 28, 2023.

The Technical Report was prepared in accordance with the Canadian Securities Administrator’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects, and can be found on the Company’s website (www.erocopper.com) and on SEDAR (www.sedar.com). A copy of the Technical Report will also be filed on EDGAR (www.sec.gov).

ABOUT ERO COPPER CORP

Ero is a high-margin, high-growth, clean copper producer with operations in Brazil and corporate headquarters in Vancouver, B.C. The Company’s primary asset is a 99.6% interest in the Brazilian copper mining company, Mineração Caraíba S.A. (“MCSA”), 100% owner of the Company’s Caraíba Operations (formerly known as the MCSA Mining Complex), which are located in the Curaçá Valley, Bahia State, Brazil and include the Pilar and Vermelhos underground mines and the Surubim open pit mine, and the Tucumã Project (formerly known as Boa Esperança), an IOCG-type copper project located in Pará, Brazil. The Company also owns 97.6% of NX Gold S.A. (“NX Gold”) which owns the Xavantina Operations (formerly known as the NX Gold Mine), comprised of an operating gold and silver mine located in Mato Grosso, Brazil. Additional information on the Company and its operations, including technical reports on the Caraíba Operations, Xavantina Operations and Tucumã Project, can be found on the Company’s website (www.erocopper.com), on SEDAR (www.sedar.com), and on EDGAR (www.sec.gov). The Company’s shares are publicly traded on the Toronto Stock Exchange and the New York Stock Exchange under the symbol “ERO”.

FOR MORE INFORMATION, PLEASE CONTACT

Courtney Lynn, VP, Corporate Development & Investor Relations
(604) 335-7504
[email protected]

CAUTION REGARDING FORWARD LOOKING INFORMATION AND STATEMENTS

This press release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation (collectively, “forward-looking statements”). Forward-looking statements include statements that use forward-looking terminology such as “may”, “could”, “would”, “will”, “should”, “intend”, “target”, “plan”, “expect”, “budget”, “estimate”, “forecast”, “schedule”, “anticipate”, “believe”, “continue”, “potential”, “view” or the negative or grammatical variation thereof or other variations thereof or comparable terminology. Forward-looking statements may include, but are not limited to, statements with respect to the future filing of the Technical Report.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual results, actions, events, conditions, performance or achievements to materially differ from those expressed or implied by the forward-looking statements, including, without limitation, risks discussed in this press release and in the Company’s Annual Information Form for the year ended December 31, 2022 and dated March 7, 2023 (the “AIF”) under the heading “Risk Factors”.

Forward-looking statements are not a guarantee of future performance. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements involves statements about the future and are inherently uncertain, and the Company’s actual results, achievements or other future events or conditions may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, those referred to herein and in the AIF under the heading “Risk Factors”.

The Company’s forward-looking statements are based on the assumptions, beliefs, expectations and opinions of management on the date the statements are made, many of which may be difficult to predict and beyond the Company’s control.

Forward-looking statements contained herein are made as of the date of this press release and the Company disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or results or otherwise, except as and to the extent required by applicable securities laws.



Catalent Announces Postponement of Third Quarter 2023 Results and Conference Call

Catalent Announces Postponement of Third Quarter 2023 Results and Conference Call

SOMERSET, N.J.–(BUSINESS WIRE)–
Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that in light of the circumstances described in the Company’s Form 12b-25 filed on May 11, 2023, with the Securities and Exchange Commission, and the Company’s ongoing focus on finalizing its financial statements and other disclosures in its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the “Form 10-Q”) and completing its quarterly closing processes and procedures, it will be postponing the release of its financial results for the third quarter of fiscal year 2023, ended March 31, 2023, and the conference call previously scheduled for Monday, May 15, 2023 at 8:15 a.m. ET, until Friday, May 19, 2023 at 8:15 a.m. ET.

Third Quarter Fiscal Year 2023 Earnings Conference Webcast

The Company now expects to release financial results for the third quarter of fiscal year 2023, ended March 31, 2023, before the market open on Friday, May 19, 2023, and will host a webcast to discuss the results at 8:15 a.m. ET on the same day. Catalent invites all interested parties to listen to the webcast and view a supplemental slide presentation, both of which will be accessible through Catalent’s website at https://investor.catalent.com. The webcast replay, along with the supplemental slides, will be available for 90 days at https://investor.catalent.com.

About Catalent

Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information www.catalent.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding management’s ongoing review of its third fiscal quarter financial statements and the release of the Company’s fiscal third quarter results. These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual future events, results or achievements to be materially different from the Company’s expectations and projections expressed or implied by the forward-looking statements. The important factors include, but are not limited to, the finalization of the Company’s third quarter financial statements, completion of the Company’s quarterly closing processes and procedures, as well as the general business, financial and accounting risks and the other important factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, filed with the U.S. Securities and Exchange Commission, or the SEC, and the Company’s other filings with the SEC. Forward-looking statements speak only as of the date of this press release and are based on information available to the Company as of the date of this press release, and the Company assumes no obligation to update such forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact:

Paul Surdez, Catalent, Inc.

(732) 537-6325

[email protected]

Media Contact:

Chris Halling

+44 (0)7580 041073

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Science Other Science Biotechnology Research Pharmaceutical General Health Health Other Health

MEDIA: